Loading organizations...
Loading organizations...
Biotechnology company developing immune-enabling therapies for infections.
Clarametyx Biosciences has raised $51.1M across 3 funding rounds.
Clarametyx Biosciences has raised $51.1M in total across 3 funding rounds.
Clarametyx Biosciences has raised $51.1M in total across 3 funding rounds.
Clarametyx Biosciences's investors include Bill Baumel, 1776, C Bio Investors, Cystic Fibrosis Foundation, JobsOhio Growth Capital, Nationwide Children, Rev1 Ventures.
Clarametyx Biosciences has raised $51.1M across 3 funding rounds. Most recently, it raised $33.0M Series A in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 5, 2024 | $33.0M Series A | Bill Baumel | 1776, C Bio Investors, Cystic Fibrosis Foundation, JobsOhio Growth Capital, Nationwide Children, Rev1 Ventures |
| Apr 4, 2022 | $3.9M Grant | ||
| Nov 18, 2020 | $14.2M Other Equity |